Advertisement

ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut

      Background & Aims

      Glucagon-like peptide-2 (GLP-2) is a 33-amino acid peptide hormone secreted by enteroendocrine cells in response to nutrient ingestion. GLP-2 stimulates crypt cell proliferation leading to expansion of the mucosal epithelium; however, the mechanisms transducing the trophic effects of GLP-2 are incompletely understood.

      Methods

      We examined the gene expression profiles and growth-promoting actions of GLP-2 in normal mice in the presence or absence of an inhibitor of ErbB receptor signaling, in Glp2r−/− mice and in Egfrwa2 mice harboring a hypomorphic point mutation in the epidermal growth factor receptor.

      Results

      Exogenous GLP-2 administration rapidly induced the expression of a subset of ErbB ligands including amphiregulin, epiregulin, and heparin binding (HB)-epidermal growth factor, in association with induction of immediate early gene expression in the small and large bowel. These actions of GLP-2 required a functional GLP-2 receptor because they were eliminated in Glp2r−/− mice. In contrast, insulin-like growth factor-I and keratinocyte growth factor, previously identified mediators of GLP-2 action, had no effect on the expression of these ErbB ligands. The GLP-2-mediated induction of ErbB ligand expression was not metalloproteinase inhibitor sensitive but was significantly diminished in Egfrwa2 mice and completed abrogated in wild-type mice treated with the pan-ErbB inhibitor CI-1033. Furthermore, the stimulatory actions of GLP-2 on crypt cell proliferation and bowel growth were eliminated in the presence of CI-1033.

      Conclusions

      These findings identify the ErbB signaling network as a target for GLP-2 action leading to stimulation of growth factor-dependent signal transduction and bowel growth in vivo.

      Abbreviations used in this paper:

      EGF (epidermal growth factor), EGFR (epidermal growth factor receptor), GLP (glucagon-like peptide), IGF-I (insulin-like growth factor-I), KGF (keratinocyte growth factor)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Drucker D.J.
        The biology of incretin hormones.
        Cell Metab. 2006; 3: 153-165
        • Buteau J.
        • Foisy S.
        • Joly E.
        • et al.
        Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor.
        Diabetes. 2003; 52: 124-132
        • Munroe D.G.
        • Gupta A.K.
        • Kooshesh F.
        • et al.
        Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
        Proc Natl Acad Sci U S A. 1999; 96: 1569-1573
        • Mayo K.E.
        • Miller L.J.
        • Bataille D.
        • et al.
        International Union of Pharmacology. XXXV. The glucagon receptor family.
        Pharmacol Rev. 2003; 55: 167-194
        • Yusta B.
        • Estall J.
        • Drucker D.J.
        GLP-2 receptor activation engages Bad and glycogen synthase kinase 3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.
        J Biol Chem. 2002; 277: 24896-24906
        • Burrin D.G.
        • Stoll B.
        • Guan X.
        • et al.
        Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.
        Endocrinology. 2005; 146: 22-32
        • Bjerknes M.
        • Cheng H.
        Modulation of specific intestinal epithelial progenitors by enteric neurons.
        Proc Natl Acad Sci U S A. 2001; 98: 12497-12502
        • Guan X.
        • Karpen H.E.
        • Stephens J.
        • et al.
        GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.
        Gastroenterology. 2006; 130: 150-164
        • Nelson D.W.
        • Sharp J.W.
        • Brownfield M.S.
        • et al.
        Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.
        Endocrinology. 2007; 148: 1954-1962
        • Yusta B.
        • Huang L.
        • Munroe D.
        • et al.
        Enteroendocrine localization of GLP-2 receptor expression.
        Gastroenterology. 2000; 119: 744-755
        • Orskov C.
        • Hartmann B.
        • Poulsen S.S.
        • et al.
        GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.
        Regul Pept. 2005; 124: 105-112
        • Sigalet D.L.
        • Wallace L.E.
        • Holst J.J.
        • et al.
        Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.
        Am J Physiol Gastrointest Liver Physiol. 2007; 293: G211-G221
        • Guan X.
        • Stoll B.
        • Lu X.
        • et al.
        GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.
        Gastroenterology. 2003; 125: 136-147
        • Dube P.E.
        • Forse C.L.
        • Bahrami J.
        • et al.
        The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
        Gastroenterology. 2006; 131: 589-605
        • Dube P.E.
        • Rowland K.J.
        • Brubaker P.L.
        Glucagon-like peptide-2 activates β-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
        Endocrinology. 2008; 149: 291-301
        • Walters J.R.
        Cell and molecular biology of the small intestine: new insights into differentiation, growth and repair.
        Curr Opin Gastroenterol. 2004; 20: 70-76
        • Koehler J.A.
        • Harper W.
        • Barnard M.
        • et al.
        Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
        Cancer Res. 2008; 68: 7897-7904
        • Luetteke N.C.
        • Phillips H.K.
        • Qiu T.H.
        • et al.
        The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.
        Genes Dev. 1994; 8: 399-413
        • Christensen J.G.
        • Vincent P.W.
        • Klohs W.D.
        • et al.
        Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor.
        Mol Cancer Ther. 2005; 4: 938-947
        • Nyati M.K.
        • Maheshwari D.
        • Hanasoge S.
        • et al.
        Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo.
        Clin Cancer Res. 2004; 10: 691-700
        • Koehler J.A.
        • Yusta B.
        • Drucker D.J.
        The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
        Mol Endocrinol. 2005; 19: 459-473
        • Nowak M.
        • Gaines G.C.
        • Rosenberg J.
        • et al.
        LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor.
        Am J Physiol Regul Integr Comp Physiol. 2000; 278: R1202-R1209
        • Solorzano C.C.
        • Ksontini R.
        • Pruitt J.H.
        • et al.
        Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.
        J Immunol. 1997; 158: 414-419
        • Citri A.
        • Yarden Y.
        EGF-ERBB signalling: towards the systems level.
        Nat Rev Mol Cell Biol. 2006; 7: 505-516
        • Helmrath M.A.
        • Erwin C.R.
        • Warner B.W.
        A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation.
        J Surg Res. 1997; 69: 76-80
        • Warner B.W.
        • Erwin C.R.
        Critical roles for EGF receptor signaling during resection-induced intestinal adaptation.
        J Pediatr Gastroenterol Nutr. 2006; 43: S68-S73
        • Dahly E.M.
        • Gillingham M.B.
        • Guo Z.
        • et al.
        Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.
        Am J Physiol Gastrointest Liver Physiol. 2003; 284: G670-G682
        • Al-Nafussi A.I.
        • Wright N.A.
        The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents.
        Virchows Arch. 1982; 40: 63-69
        • Drucker D.J.
        • Ehrlich P.
        • Asa S.L.
        • et al.
        Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
        Proc Natl Acad Sci U S A. 1996; 93: 7911-7916
        • Chaet M.S.
        • Arya G.
        • Ziegler M.M.
        • et al.
        Epidermal growth factor enhances intestinal adaptation after massive small bowel resection.
        J Pediatr Surg. 1994; 29: 1035-1039
        • Scott R.B.
        • Kirk D.
        • MacNaughton W.K.
        • et al.
        GLP-2 augments the adaptive response to massive intestinal resection in rat.
        Am J Physiol. 1998; 275: G911-G921
        • Lee K.K.
        • Jo H.J.
        • Hong J.P.
        • et al.
        Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage.
        Int J Radiat Oncol Biol Phys. 2008; 71: 1230-1235
        • Torres S.
        • Thim L.
        • Milliat F.
        • et al.
        Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.
        Int J Radiat Oncol Biol Phys. 2007; 69: 1563-1571
        • Drucker D.J.
        • Yusta B.
        • Boushey R.P.
        • et al.
        Human [Gly2]-GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis.
        Am J Physiol. 1999; 276: G79-G91
        • Egger B.
        • Carey H.V.
        • Procaccino F.
        • et al.
        Reduced susceptibility of mice overexpressing transforming growth factor α to dextran sodium sulphate colitis.
        Gut. 1998; 43: 64-70
        • Ribbons K.A.
        • Howarth G.S.
        • Davey K.B.
        • et al.
        Subcutaneous but not intraluminal epidermal growth factor stimulates colonic growth in normal adult rats.
        Growth Factors. 1994; 10: 153-162